We are live on ! Find out more
WC

Woodstock Corp Portfolio holdings

AUM $1.2B
1-Year Est. Return 26.37%
This Fund
S&P 500
This Quarter Est. Return
+10.11%
1 Year Est. Return
+26.37%
3 Year Est. Return
+96.13%
5 Year Est. Return
+140.78%
10 Year Est. Return
+511.59%
AUM
$614M
AUM Growth
+$40M
Cap. Flow
-$7.96M
Cap. Flow %
-1.3%
Top 10 Hldgs %
29.7%
Holding
164
New
2
Increased
37
Reduced
65
Closed
9

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$5.57M
2
IRM icon
Iron Mountain
IRM
+$626K
3
MMM icon
3M
MMM
+$589K
4
KYNB
Kyntra Bio
KYNB
+$490K
5
RTN
Raytheon Company
RTN
+$442K

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$9.2M
2
SLB icon
SLB Ltd
SLB
+$1.83M
3
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
+$1.01M
4
HAIN icon
Hain Celestial
HAIN
+$727K
5
GWPH
GW Pharmaceuticals Plc American Depositary Shares
GWPH
+$605K

Sector Composition

Rank Sector Weight
1 Healthcare 24.16%
2 Technology 22.86%
3 Industrials 9.44%
4 Consumer Staples 8.89%
5 Communication Services 8.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RARE icon
151
Ultragenyx Pharmaceutical
RARE
$2.46B
– –
-11,212
Closed -$480K
GWPH
152
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
– –
-5,256
Closed -$605K
DNR
153
DELISTED
Denbury Resources, Inc.
DNR
– –
-37,471
Closed -$45K
NE
154
DELISTED
Noble Corporation
NE
– –
-14,535
Closed -$18K
UPL
155
DELISTED
Ultra Petroleum Corp. Common Stock
UPL
– –
-10,041
Closed -$2K
CELG
156
DELISTED
Celgene Corp
CELG
– –
-92,635
Closed -$9.2M
3 4 5 6
7

Similar funds

SGDR
SPX Gestao de Recursos Rio De Janeiro, Brazil $1.2B AUM 59.06% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
FCCPG
FountainVest China Capital Partners GP3 Grand Cayman, Cayman Islands $1.2B AUM 6.95% 1-Year Est. Return
MB
MidFirst Bank Oklahoma City, Oklahoma $1.21B AUM
AIM
Anchor Investment Management Columbia, South Carolina $1.2B AUM 17.33% 1-Year Est. Return
TIM
Tortoise Investment Management White Plains, New York $1.21B AUM 13.04% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.4% 1-Year Est. Return
CS
Central Securities New York $1.21B AUM 19.91% 1-Year Est. Return

Woodstock Corp's Q4 2019 Portfolio in Review

As of Q4 2019, Woodstock Corp held 164 positions worth $614M, up 7% from $574M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Woodstock Corp's Q4 2019 filing shows 2 new, 37 increased, 65 reduced and 9 closed positions. Its largest new stake was Bristol-Myers Squibb Company Contingent Value Rights: 90,585 shares worth $273K. The largest sale was Celgene Corp, an estimated $9.2M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Technology and Industrials.

  • Woodstock Corp's largest Q4 2019 buy was Bristol-Myers Squibb Company Contingent Value Rights: 90,585 shares worth $273K.
  • Woodstock Corp added most to Bristol-Myers Squibb in Q4 2019, an estimated $5.57M increase.
  • Woodstock Corp's biggest Q4 2019 reduction was SLB Ltd, cutting an estimated $1.83M.
  • Woodstock Corp fully exited Celgene Corp in Q4 2019, selling an estimated $9.2M.
  • Woodstock Corp's ten largest holdings make up 30% of its $614M portfolio in Q4 2019.
  • Woodstock Corp opened 2 new positions and closed 9 in Q4 2019.
  • Woodstock Corp's portfolio value rose 7% quarter-over-quarter to $614M.

Based on Woodstock Corp's 13F filing for Q4 2019, filed 13 Jan 2020.